Atul Bhattaram, PhD
- 2Articles
- 9.6KReads1
- 2011–2012Active
- 22Collaborators
- 106Citations2
About
Atul Bhattaram, PhD, has published research focused on pharmacogenetics and antidepressant treatments, particularly examining CYP2D6 genotype-guided dosing of pimozide and the clinical basis for vilazodone approval. The work spans adult and pediatric populations and addresses major depressive disorder. Bhattaram's contributions appeared in Psychiatrist.com between 2011 and 2012, often collaborating with Issam Zineh and others.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
